ZNF330 Inhibitors
ZNF330 Inhibitors are compounds that serve to inhibit the functional activity of ZNF330 through a variety of mechanisms. For instance, Clotrimazole could diminish ZNF330's DNA-binding capability by interfering with cytochrome P450 dependent processes. Similarly, Mithramycin A binds to G-C rich DNA regions, potentially blocking ZNF330's DNA binding sites and therefore its ability to regulate transcription. PD 98059's inhibition of the MEK pathway could indirectly inhibit ZNF330's function by affecting transcription factor phosphorylation and energy status within the cell. Triptolide and Curcumin act more broadly by affecting the transcription machinery and multiple signaling pathways, respectively, which could lead to inhibition of ZNF330's interactions with co-regulatory proteins or alter its transcriptional activity. LY 294002's impact on PI3K/AKT signaling and Trichostatin A's effecton chromatin structure offer additional routes by which ZNF330's regulatory functions could be inhibited, either by modulating protein interactions or by changing the accessibility of DNA to the protein.
Continuing with the theme of altering the cellular environment to inhibit ZNF330, 5-Azacytidine could disrupt ZNF330's target gene regulation by altering the methylation status of DNA, while Staurosporine might affect ZNF330's activity by modifying the phosphorylation status of its interacting proteins. Chetomin's disruption of HIF pathways could lead to transcriptional changes that diminish ZNF330's role under hypoxic conditions, and Alsterpaullone's inhibition of cyclin-dependent kinases may affect ZNF330 during cell cycle progression. Each of these inhibitors targets different aspects of the cellular machinery and signaling pathways, resulting in a comprehensive approach to diminishing the transcriptional regulatory activities of ZNF330 without affecting its expression levels or general cellular pathways. These inhibitors achieve their effects through diverse biochemical actions, from direct DNA binding interference to modulation of protein-protein interactions and alterations in the cell's signaling status, all converging on the common outcome of inhibiting ZNF330.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Clotrimazole | 23593-75-1 | sc-3583 sc-3583A | 100 mg 1 g | $42.00 $57.00 | 6 | |
An imidazole antifungal that binds to the heme group of cytochrome P450. This binding can interfere with P450 dependent processes which might be necessary for the post-translational modification of ZNF330, thereby diminishing its DNA-binding capability. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Binds to G-C rich regions of DNA, potentially preventing ZNF330 from accessing its DNA binding sites, thus diminishing its transcriptional regulatory activity. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
A diterpenoid triepoxide that has been shown to inhibit the transcriptional activity of certain proteins by affecting the transcription machinery, potentially diminishing ZNF330's ability to regulate gene expression. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
A biologically active polyphenolic compound of turmeric that can modulate multiple signaling pathways, such as NF-κB, which could lead to the inhibition of ZNF330 by altering the expression or activity of co-regulatory proteins. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A selective inhibitor of MEK, which could prevent the phosphorylation of transcription factors and co-regulators that interact with ZNF330, thereby diminishing its functional activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that may alter AKT signaling, potentially modulating co-regulatory protein interactions with ZNF330 and diminishing its transcriptional regulatory functions. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor that can change chromatin structure and thus affect the DNA binding of transcription factors including ZNF330, potentially diminishing its regulatory activity. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that can alter gene expression patterns, potentially impacting ZNF330's ability to regulate its target genes by changing the methylation status of DNA. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor that can influence multiple signaling pathways, potentially affecting ZNF330's activity by altering the phosphorylation status of proteins that interact with ZNF330 or modulate its function. | ||||||
Chetomin | 1403-36-7 | sc-202535 sc-202535A | 1 mg 5 mg | $186.00 $674.00 | 10 | |
A disruptor of the hypoxia-inducible factor (HIF) pathway which could lead to altered transcriptional regulation by ZNF330 due to changes in cellular responses to hypoxia. | ||||||